MRK vs ZBH
By Alex · Tickerpine
Merck & Co., Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZBH |
|---|---|---|
| Price | $147.76 | $103.21 |
| Market cap | $364.26B | $19.53B |
| P/E ratio | 149.3 | 26.1 |
| ROE | 5.06% | 6.03% |
| Profit margin | 3.64% | 8.95% |
| Revenue growth | 4.70% | 3.10% |
| Dividend yield | 2.30% | 0.93% |
| Beta | 0.12 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZBH in plain English
- MRK is the bigger company — about 18.6× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 26.1 vs 149.3).
- ZBH earns a higher return on equity (6% vs 5%).
- MRK is growing revenue faster (5% vs 3%).
- MRK has the higher dividend yield (2.30% vs 0.93%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.